- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: LUMIGAN® (bimatoprost ophthalmic solution) 0.01%
Total 473 results
-
AllerganCompletedLong-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionOcular Hypertension | GlaucomaSpain, France, Belgium, Israel, United Kingdom, Poland, Italy, Czechia, Germany, Hungary
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
Amneal Pharmaceuticals, LLCCBCC Global Inc.; Amneal EU, LimitedNot yet recruitingOcular Hypertension | Open-angle GlaucomaUnited States
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleAustria
-
Amneal Pharmaceuticals, LLCCBCC Global ResearchRecruitingOcular Hypertension | Glaucoma, Open-AngleUnited States
-
Mankind Pharma LimitedCBCC Global ResearchCompleted
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleSwitzerland
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleUnited States
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleCanada, United States
-
AllerganCompletedOcular Hypertension | Open-Angle GlaucomaBelgium
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
Alcon ResearchCompletedOcular Hypertension | Glaucoma
-
Alcon ResearchCompletedOcular Hypertension | Glaucoma | Open-Angle Glaucoma
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedEyelash HypotrichosisUnited States
-
Laboratoires TheaCompletedPrimary Open Angle Glaucoma | Ocular HypertensionFrance
-
AllerganCompletedOcular Hypertension | Glaucoma, Primary Open AngleGermany
-
University of California, San FranciscoCompletedAlopecia AreataUnited States
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleKorea, Republic of
-
Singapore National Eye CentreAllerganUnknownGlaucoma, Angle-ClosureSingapore
-
AllerganCompletedOcular Hypertension | Glaucoma, Primary Open AngleTaiwan
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedHypotrichosisUnited States
-
AllerganCompletedEyelashesUnited States, Canada
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedOcular Hypertension | Open-Angle GlaucomaUnited States
-
AllerganCompletedOcular Hypertension | Open-angle GlaucomaChina
-
AllerganCompletedAlopecia Areata | Eyelash HypotrichosisUnited States, Brazil
-
Aerie PharmaceuticalsCompletedOcular Hypertension | Open Angle GlaucomaJapan
-
AllerganCompletedOcular Hypertension | Glaucoma, Primary Open AngleCanada
-
Northwestern UniversityAllerganCompletedIntraocular Pressure | Nail Growth CessationUnited States
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleChina
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleChina
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleCanada
-
AllerganCompletedOcular Hypertension | Open Angle GlaucomaUnited States
-
Tulane UniversityAllerganCompleted
-
Gian Sagar Medical College and HospitalWithdrawnVitiligo | Repigmentation
-
University of California, San DiegoCompletedOcular Hypertension | Glaucoma | Intraocular PressureUnited States
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedHypotrichosisUnited States
-
Summa Health SystemCompletedGlaucoma | Application Site Pigmentation ChangesUnited States
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedOcular Hypertension | Primary Open-Angle GlaucomaUnited States
-
Salus UniversityNot yet recruitingNormal Tension GlaucomaUnited States
-
Aerie PharmaceuticalsCompletedOcular Hypertension | Open Angle GlaucomaUnited States
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleUnited States